Stryker (SYK) Return on Capital Employed (2009 - 2026)
Stryker's (SYK) quarterly Return on Capital Employed came in at 12.24% in Q1 2026, down 1390.0% year-on-year from 0.95% in Q1 2025, and down 0.72% on a QoQ basis from 12.33% in Q4 2025.
Stryker (SYK) Return on Capital Employed (2009 - 2026) Analysis & Trends
Stryker (SYK) has 18 years of Return on Capital Employed data on file, last reported at 12.24% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 1390.0% year-over-year to 12.24% in Q1 2026; TTM through Mar 2026 was 12.24%, a 1390.0% decrease from a year earlier, with the FY2025 full-year figure at 13.0%, up 209.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 12.24%, down from 12.33% in the prior quarter.
- Over the last five years, Return on Capital Employed for SYK reached as high as 32.3% in Q4 2023 and fell as low as 61.03% in Q2 2024.
- Historically, Return on Capital Employed has averaged 8.34% across 5 years, with a median of 10.88% in 2023.
- Across the five-year window, Return on Capital Employed plunged 8774 bps in 2024 and soared 8374 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 9.43% in 2022, then surged by 243 bps to 32.3% in 2023, then declined by 18 bps to 26.57% in 2024, then sank by 54 bps to 12.33% in 2025, then decreased by 1 bps to 12.24% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 12.24% in Q1 2026, 12.33% in Q4 2025, and 9.33% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 11.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.24% |
| Dec 31, 2025 | 12.33% |
| Sep 30, 2025 | 9.33% |
| Jun 30, 2025 | 22.71% |
| Mar 31, 2025 | 26.14% |
| Dec 31, 2024 | 26.57% |
| Sep 30, 2024 | -57.11% |
| Jun 30, 2024 | -61.03% |
| Mar 31, 2024 | 31.70% |
| Dec 31, 2023 | 32.30% |
| Sep 30, 2023 | 30.63% |
| Jun 30, 2023 | 10.88% |
| Mar 31, 2023 | 10.10% |
| Dec 31, 2022 | 9.43% |
| Sep 30, 2022 | 9.05% |
| Jun 30, 2022 | 8.24% |
| Mar 31, 2022 | 8.30% |
| Dec 31, 2021 | 8.66% |
| Sep 30, 2021 | 8.53% |
| Jun 30, 2021 | 9.54% |